Document is current
Any future updates will be listed below
-
Authors
Asl, Aysan Mahmoudi https://orcid.org/0000-0002-2231-6650
Toribio-Guzmán, Jose Miguel
van der Roest, Henriëtte
Castro-González, Álvaro
Malfaz, María
Salichs, Miguel A.
Martin, Manuel Franco
-
Funding
Funding for this research was provided by:
H2020 Marie Skłodowska-Curie Actions (813196)
- License Information
-
More Information
Article History
Received: 27 October 2022
Accepted: 23 November 2022
First Online: 5 December 2022
Declaration
:
: Zamora Health Area Medication Research Ethics Committee approved the research protocol under registration number 574. The foreseeable risks and inconveniences of the research are acceptable of the expected benefits. The planned procedure for information and obtaining informed consent is considered adequate. Participants and their next to kin will be requested to sign an informed consent form before the study begins.
: Not applicable.
: No competing interest was declared.
